Nocturnal emergency department visits, duration of symptoms and risk of hospitalisation among adults with asthma exacerbations: a multicentre observational study by Yasuda, Hideto et al.
Nocturnal emergency department
visits, duration of symptoms and
risk of hospitalisation among
adults with asthma exacerbations:
a multicentre observational study
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Yasuda, Hideto, Yusuke Hagiwara, Hiroko Watase, and Kohei
Hasegawa. 2016. “Nocturnal emergency department visits,
duration of symptoms and risk of hospitalisation among adults with
asthma exacerbations: a multicentre observational study.” BMJ




Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Nocturnal emergency department visits,
duration of symptoms and risk of
hospitalisation among adults with
asthma exacerbations: a multicentre
observational study
Hideto Yasuda,1,2 Yusuke Hagiwara,3 Hiroko Watase,4 Kohei Hasegawa,5
on behalf of the Japanese Emergency Medicine Network Investigators
To cite: Yasuda H,
Hagiwara Y, Watase H, et al.
Nocturnal emergency
department visits, duration of
symptoms and risk of
hospitalisation among adults
with asthma exacerbations: a
multicentre observational
study. BMJ Open 2016;6:
e010670. doi:10.1136/
bmjopen-2015-010670
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2015-010670).
Received 4 December 2015
Revised 9 July 2016
Accepted 11 July 2016







Objectives: We sought to compare the characteristics
of patients with asthma presenting to the emergency
department (ED) during the night-time with those of
patients presenting at other times of the day, and to
determine whether the time of ED presentation is
associated with the risk of hospitalisation.
Design and setting: A multicentre chart review study
of 23 EDs across Japan.
Participants: Patients aged 18–54 years with a
history of physician-diagnosed asthma, presented
to the ED between January 2009 and
December 2011
Outcome measures: The outcome of interest was
hospitalisation, including admissions to an observation
unit, inpatient unit and intensive care unit.
Results: Among the 1354 patients (30.1% in the
night-time group vs 69.9% in the other time group)
included in this study, the median age was 34 years and
∼40% were male. Overall 145 patients (10.7%) were
hospitalised. Patients in the night-time group were more
likely to have a shorter duration of symptoms
(≤3 hours) before ED presentation than those in the
other time group (25.9% in night-time vs 13.4% in
other times; p<0.001). In contrast, there were no
significant differences in respiratory rate, initial peak
expiratory flow or ED asthma treatment between the two
groups (p>0.05). Similarly, the risk of hospitalisation
did not differ between the two groups (11.3% in night-
time vs 10.5% in other times; p=0.65). In a
multivariable model adjusting for potential confounders,
the risk of hospitalisation in the night-time group was
not statistically different from the other time group
(OR, 1.10; 95% CI 0.74 to 1.61; p=0.63).
Conclusions: This multicentre study in Japan
demonstrated no significant difference in the risk of
hospitalisations according to the time of ED
presentation.
INTRODUCTION
Asthma is an inﬂammatory disease of the
airways and frequently characterised by
marked changes in symptoms according to a
circadian rhythm. More than two-thirds of
patients with asthma experience nocturnal
exacerbations.1–3 It has been speculated that
the treatment of patients presenting to the
emergency department (ED) with asthma
exacerbation may be less successful at the
night-time than during the other times of
the day because acute asthma severity
increases at night.4 However, other studies
from North America have failed to demon-
strate a consistent relationship between noc-
turnal visits to the ED and poor outcomes,
such as an increased risk of hospitalisation.5–8
In addition, to the best of our knowledge, the
relationship between the time of the ED pres-
entation and acute outcomes of asthma
exacerbation has not been studied in other
settings (eg, Asian countries).
To address the knowledge gap in the litera-
ture, using the data from a multicentre study,
we aimed to compare the characteristics of
patients presenting to the ED for asthma
exacerbation at the night-time (between mid-
night and 07:59) with those of patients pre-
senting at the other times of the day
(between 08:00 and 23:59), and to investigate
Strengths and limitations of this study
▪ This is an analysis of a large multicentre chart
review study from 23 emergency departments
(EDs) across Japan.
▪ As with observational study, the lack of associ-
ation between nocturnal ED visits and risk of
hospitalisation might be confounded by unmeas-
ured factors, such as the time of onset of
asthma exacerbation and institutional variation in
resource usage.
▪ Our inferences may not be generalisable to rural
or non-academic EDs or other healthcare set-
tings outside of Japan.
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whether the time of ED presentation is associated with
the risk of hospitalisation for asthma exacerbation.
METHODS
Study design and settings
This is a secondary analysis of a multicentre chart review
study to characterise adult patients with asthma exacer-
bation and their management in 23 EDs across
Japan.9 10 This study was coordinated by the Japanese
Emergency Medicine Network ( JEMNet) in collabor-
ation with the US-based Emergency Medicine Network
(http://www.emnet-usa.org). The JEMNet (http://
jemnet.asia/wp) is a consortium of 23 academic and
community hospitals from different geographic regions
across Japan. During the period of this study, all of the
EDs were staffed by ED-based attending physicians. The
study was approved by the Institutional Review Board of
each participating centre (see the Acknowledgements
section)’ and Massachusetts General Hospital.
Study population
Using the International Classiﬁcation of Diseases, Tenth
Revision, Clinical Modiﬁcation (ICD-10-CM) code J45.xx,
each participating hospital identiﬁed all ED visits with a
principal ED or hospital discharge diagnosis of asthma
from hospital administrative records from 1 January
2009 through 1 December 2011. Patients aged 18–
54 years, with a history of physician-diagnosed asthma
before the index ED visit were eligible for the analysis.
We excluded (1) visits made by patients with a history of
physician-diagnosed chronic obstructive pulmonary
disease (COPD), emphysema or chronic bronchitis, (2)
transfer visits, (3) repeat visits by the same patient or (4)
visits not largely prompted by an asthma exacerbation.
In the case of repeat visits, only the ﬁrst ED visit during
the study period was included in the analysis.
Data collection and measurements
Onsite chart abstractors reviewed 60 randomly selected
ED charts from January to December 2011. If sites had
<60 charts during this period, the abstractors reviewed
eligible charts dating back to January 2009 in order to
reach the target. All chart abstractors were emergency
physicians or emergency medicine residents who had
been trained in a 1-hour online lecture. They were
required to complete practice charts, which were
assessed against a ‘criterion standard’; those whose
accuracy was <80% per chart had to be retrained.
The following data were abstracted using a standar-
dised form: patients’ demographics, chronic asthma
characteristics, asthma exacerbation presentation, man-
agement in the ED and at discharge, and ED dispos-
ition. This standardised form has been used in multiple
US-based studies conducted by the Emergency Medicine
Network.6 9–16
Outcome measures
The outcome of interest was hospitalisation, deﬁned by
an admission to an observation unit, inpatient unit and
intensive care unit.
Statistical analysis
For the purpose of this analysis, patients were cate-
gorised into two groups according to their time at ED
presentation:6 the night-time (between midnight and
07:59) and the other times (between 08:00 and 23:59).
First, the unadjusted association of the time of ED pres-
entation with the patient characteristics and ED manage-
ment was examined using the χ2 test and Mann-Whitney
U test, as appropriate. Next, to examine the association
of the time of ED presentation with the risk of hospitali-
sation, we ﬁtted a multivariable logistic regression model
adjusting for eight potential confounders that were
selected based on a priori knowledge and clinical plausi-
bility: age, sex, comorbidity, history of intubation for
asthma, history of ED visits over the last year, history of
hospitalisations for asthma in the last year and the
current use of inhaled corticosteroids and leukotriene
modiﬁers.
Missing indicator methods were used to address
missing data. ORs were presented with 95% CIs.
Statistical analyses were performed using JMP V.10.0 soft-
ware (SAS Institute, Cary, North Carolina, USA) and all
tests were two-tailed using a statistical signiﬁcance value
of p<0.05.
RESULTS
We identiﬁed 1380 patients who presented to one of the
23 EDs with asthma exacerbation. Of these, we excluded
26 patients who had missing data on the time of ED
presentation (non-analytic cohort), and the remaining
1354 patients (98%) had data on the time of ED presen-
tation (analytic cohort), and were included in the
current analysis. The analytic and non-analytic cohorts
had similar demographics, chronic asthma characteri-
stics, ED presentation and ED disposition (all p>0.05;
data not shown).
Demographic characteristics and chronic asthma factors
Overall, the median age was 35 years (IQR, 26–43 years),
42% were male and 11% were hospitalised to the ED.
Of 1354 patients in the analytic cohort, 408 (30%) pre-
sented to the ED at the night-time (the night-time
group) and 946 (70%) at the other times (the other
time group). There were no signiﬁcant differences in
the demographic characteristics, chronic asthma
characteristics or current asthma medications between
the two groups (table 1).
ED course of patients with asthma exacerbation
Asthma exacerbation presentation and ED course,
according to the time of ED presentation, are shown in
table 1. Patients in the night-time group were more
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likely to have a shorter duration of symptoms (≤3 hours)
prior to their ED presentation compared to those in the
other time group (26% vs 13%; p<0.001). However,
there were no signiﬁcant differences in the presentation
(eg, respiratory rate, initial peak expiratory ﬂow) or
acute asthma treatment in the ED between the groups.
Similarly, the proportion of the patients hospitalised
from the ED did not differ signiﬁcantly between the two
groups (11% vs 11%; p=0.65). Likewise, in the multivari-
able logistic regression model adjusting for eight
potential confounders, the time of ED presentation was
not associated with the risk of hospitalisation (OR for
night-time vs other times, 1.10; 95% CI 0.74 to 1.61;
p=0.63; table 2).
DISCUSSION
In this multicentre study of 1354 ED patients with
asthma exacerbation, ∼30% of the patients presented to
the ED at the night-time. These patients presented to
Table 1 Demographic characteristics, chronic asthma factors and emergency department (ED) course of patients with







n=946 (70%) p Value
Demographics
Age (year), median (IQR) 34 (26–42) 35 (26–43) 0.55
Female sex 224 (55%) 571 (60%) 0.06
Not pregnant* 165 (90%) 423 (93%) 0.32
Comorbidity 37 (9%) 114 (12%) 0.11
Age at the diagnosis of asthma (year), median (IQR) 19 (6–30) 20 (9–30) 0.29
Current smoking 130 (45%) 268 (40%) 0.07
Chronic asthma factors
History of intubation for asthma 10 (4%) 11 (2%) 0.08
History of hospitalisation for asthma 95 (37%) 189 (33%) 0.30
Ever use of systemic corticosteroids 113 (52%) 266 (50%) 0.62
ED visit for asthma in last year 70 (25%) 144 (21%) 0.15
Hospitalised for asthma in last year 26 (8%) 52 (7%) 0.58
Current use of inhaled corticosteroids 113 (29%) 290 (33%) 0.15
Current use of oral methylxanthines 49 (12%) 99 (11%) 0.54
Current use of leukotriene modifiers 51 (13%) 96 (11%) 0.30
Presentation and ED course
Duration of symptoms before ED arrival <0.001
≤3 hours 103 (26%) 122 (13%)
4–11 hours 103 (26%) 181 (20%)
12–24 hours 77 (20%) 219 (24%)
1–3 days 71 (18%) 244 (27%)
4–7 days 24 (6%) 93 (10%)
>7 days 19 (5%) 51 (6%)
Prehospital treatment 45 (12%) 110 (12%) 0.64
Initial respiratory rate (breaths/min), median (IQR) 21 (18-25) 20 (18-24) 0.13
Initial oxygen saturation on room air (%), median (IQR) 96 (93-98) 96 (94-98) 0.03
Initial PEF (L/min), median (IQR)† 205 (143-258) 200 (150-290) 0.61
Number of inhaled β-agonists in 1 hour from ED
presentation, median (IQR)
1 (1-2) 1 (1-2) 0.09
Number of inhaled β-agonists in ED, median (IQR) 1 (1-2) 1 (1-2) 0.38
Systemic corticosteroids in ED 160 (39%) 409 (43%) 0.17
Intravenous magnesium in ED 5 (1%) 9 (1%) 0.65
ED disposition 0.62
Observation unit 5 (1%) 9 (1%)
Hospital ward 37 (9%) 81 (9%)
Intensive care unit 4 (1%) 9 (1%)
Sent home‡ 356 (87%) 841 (89%)
Others (eg, left against medical advice) 6 (2%) 6 (1%)
Data were presented as number (%) unless otherwise indicated.
*Analysed for 183 (44.9%) female patients in the night-time group and 457 (48.3%) female patients in the other group.
†Analysed for 32 (7.8%) patients in the night-time group and 77 (8.1%) patients in the other time group with initial PEF available.
‡Analysed for 356 (87.3%) patients in the night-time group and 841 (88.9%) patients in the other time group who were discharged to home.
ED, emergency department; PEF, peak expiratory flow.
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the ED with a shorter duration of symptoms compared
to those who presented to the ED at the other times. In
contrast, our data did not indicate any circadian differ-
ence in the risk of hospitalisation in ED patients with
asthma exacerbations.
Results in context
Despite the clinical importance, few studies have exam-
ined the relationship of clinical characteristics of asthma
exacerbation with nocturnal asthma in the recent years.
Several studies have reported that patients with noctur-
nal asthma had a higher morbidity and inhospital
mortality compared to others.4 17–19 In contrast, in
agreement with our observations, previous North
American studies of ED patients with asthma exacerba-
tion did not ﬁnd a signiﬁcant association between the
time of ED presentation and the risk of hospitalisation.6–8
For example, Brenner et al,6 by analysing the data of a
multicentre prospective cohort of 2494 ED adult patients
(aged 18–54 years) with asthma exacerbation in the USA
and Canada, reported no association between nocturnal
visits and risks of hospitalisation. The reasons for the
apparent discrepancies between the studies are likely
multifactorial—for example, the differences in study
design, patient population, setting or any combination
of these factors. Indeed, the aforementioned studies that
reported a higher morbidity in patients with nocturnal
asthma were conducted in the inpatient setting17 19
while the studies that demonstrated the lack of morbid-
ity association,6–8 including our work, were conducted in
the ED setting. These ED data from different healthcare
systems (the USA, Canada and Japan) collectively
suggest that nocturnal ED visits for asthma exacerbation
may not be associated with the more-severe acute
asthma outcomes in ED patients, unlike such cases in
hospitalised patients.
Alternatively, non-biological factors, such as access to
healthcare including primary and asthma specialist care,
patient health behaviours, use of long-term controllers
and chronic and acute severity of asthma, also are likely
to have contributed to the discrepancy. Indeed, in our
study, the proportion of inhaled corticosteroid use prior
to the ED visit (32%) was higher than the previous
studies, although it remained suboptimal. The higher
proportion of patients with long-term controller use in
our study might also have affected the acute asthma sever-
ity and response to therapy, and further contributed to
the absence of signiﬁcant association between the noc-
turnal ED visits for asthma exacerbation and the risk
of hospitalisation. Our multicentre study of a large
number of ED adults builds on these prior studies that
examined the risk of hospitalisation by time of ED pres-
entation and extends them by conducting a multicentre
study in Japan.
Potential limitations
We acknowledge several potential limitations of this
study. First, this multicentre study relied on chart review
for data collection, and hence errors in data measure-
ment are possible. However, we used a previously
applied standardised data collection system with uniform
deﬁnitions and rigorous training, which achieved a
high interobserver agreement (κ-statistics, 0.56–1.00
(moderate-to-perfect agreement)).9 Second, our study
had no information on the reasons for nocturnal ED
visits. Third, as with any observational study, the lack of
association between nocturnal ED visits and risk of hos-
pitalisation might be confounded by unmeasured
factors, such as the time of onset of asthma exacerbation
and institutional variation in resource usage. Indeed, in
this multicentre study, we did not standardise criteria for
hospitalisation across the 23 participating EDs. Fourth,
the limited age range (18–54 years) in this study may
limit the generalisability of our ﬁndings. However, we
chose this age range to limit a potential contamination
of older patients with COPD or asthma-COPD overlap
syndrome that may bias the inferences. Finally, our
sample consisted predominantly of urban, academic EDs
in Japan. Our study population had a relatively high
chronic severity burden (eg, 22% of patients had at least
one ED visit for asthma in the preceding year) and high
acute severity (eg, 8% resulted in hospitalisation),
although these proportions were lower than those in the
recent multicentre study from the USA.20 In addition,
the participating EDs provided acute asthma care that
was imperfectly concordant to the recommendations in
the asthma guidelines.9 Therefore, our inferences may
not be generalisable to rural or non-academic EDs or
other healthcare settings outside of Japan. Nevertheless,
multiple studies arrived at a similar conclusion (ie, no
association between the time of ED presentation and
risk of hospitalisation), despite differing populations and
healthcare settings,6–8 potentially enhancing the general-
isability of our inferences.
Table 2 Unadjusted and adjusted association of time of emergency department presentation with risk of hospitalisation
Time of ED presentation
Unadjusted analysis
OR (95% CI) p Value
Multivariable analysis*
OR (95% CI) p Value
08:00–23:59 1.00 (reference) – 1.00 (reference) –
Midnight–07:59 1.09 (0.75 to 1.57) 0.65 1.10 (0.74 to 1.61) 0.63
*Multivariable analysis adjusted for age, sex, comorbidity, history of intubation for asthma, history of admissions for asthma in the last year,
history of ED visits over the last year, current use of inhaled corticosteroids and leukotriene modifiers.
ED, emergency department.
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CONCLUSION
In this multicentre analysis of 1354 ED patients with
asthma exacerbation, we found that many patients pre-
sented to the ED at the night-time. Our data also
demonstrated no signiﬁcant difference in the risk of hos-
pitalisations according to the time of ED presentation.
The reasons for nocturnal ED visits for asthma exacerba-
tion are multifactorial—for example, acute asthma sever-
ity, access to the healthcare system and patient
behaviour. Our data should facilitate further investiga-
tion to disentangle the complex web of these factors.
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